Analyses of surface markers on cells present within the UCB CD34− SP
| Immunophenotype . | UCB CD34− SP . |
|---|---|
| CD(16/56)+ | 15%-32% |
| CD2+ | 18%-38% |
| CD3+ | 10%-29% |
| CD4+ | 1.7%-8.1% |
| CD5+ | 12%-51% |
| CD14+ | none detected |
| CD33+ | none detected |
| CD19+ | none detected |
| CD71+ | none detected |
| Immunophenotype . | UCB CD34− SP . |
|---|---|
| CD(16/56)+ | 15%-32% |
| CD2+ | 18%-38% |
| CD3+ | 10%-29% |
| CD4+ | 1.7%-8.1% |
| CD5+ | 12%-51% |
| CD14+ | none detected |
| CD33+ | none detected |
| CD19+ | none detected |
| CD71+ | none detected |
The UCB SP was analyzed for the expression of various lineage-specific antigens with the use of a highly stringent gate to define the SP region (n = 2 to 3 for each marker examined).
UCB indicates umbilical cord blood; SP, side population.